To hear about similar clinical trials, please enter your email below
Trial Title:
The Pancreas Interception Center (PIC) for Early Detection, Prevention, and Novel Therapeutics
NCT ID:
NCT05692596
Condition:
Pancreatic Ductal Adenocarcinoma
Pancreatic Cyst
Chronic Pancreatitis
Fatty Pancreas
Genetic Pancreatic Cancer
Genetic Pancreatitis
BRCA Mutation
Lynch Syndrome
FAP
Familial Atypical Multiple Mole-Melanoma
PALB2 Gene Mutation
Peutz-Jeghers Syndrome
Ataxia Telangiectasia
Conditions: Official terms:
Colorectal Neoplasms, Hereditary Nonpolyposis
Pancreatic Cyst
Peutz-Jeghers Syndrome
Dysplastic Nevus Syndrome
Pancreatitis
Pancreatitis, Chronic
Ataxia Telangiectasia
Telangiectasis
Syndrome
Conditions: Keywords:
pancreas
database
Study type:
Observational
Overall status:
Recruiting
Study design:
Time perspective:
Prospective
Intervention:
Intervention type:
Other
Intervention name:
Data collection
Description:
Investigators will compile data typically collected clinically. This data will include
demographics, cancer screening procedures, cancer diagnosis and staging, chemotherapy,
immunotherapy, radiation therapy, surgery, comorbidities, medication use, lifestyle and
other cancer risk factors, quality of life, vital status, and molecular data generated
from specimens collected clinically.
Arm group label:
All participants
Summary:
The long-term goal of our PIC is to develop effective strategies that can be applied
clinically at the point-of-care to prevent, intercept, or detect PDAC at an early stage,
thereby reducing PDAC burden and saving lives.
Criteria for eligibility:
Study pop:
Patients presenting at the Moffitt GI clinic
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- 18 years of age or older
- Moffitt Cancer Center patients presenting with a pancreatic cyst, and/or inherited
syndrome that predisposes them to pancreatic ductal adenocarcinoma (PDAC)
- Moffitt Cancer Center patients undergoing evaluation for localized/early stage PDAC.
- Moffitt Cancer Center patients with a combination of PDAC risk factors such as a
history of chronic or new-onset diabetes, pancreatitis, obesity, tobacco exposure,
toxin exposure and/or heavy alcohol consumption.
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
Accepts Healthy Volunteers
Locations:
Facility:
Name:
Moffitt Cancer Center
Address:
City:
Tampa
Zip:
33617
Country:
United States
Status:
Recruiting
Contact:
Last name:
Toni Basinski
Phone:
813-745-6360
Email:
toni.basinski@moffitt.org
Investigator:
Last name:
Shaffer Mok, MD, MBS
Email:
Principal Investigator
Investigator:
Last name:
James R Costello, MD, PhD
Email:
Sub-Investigator
Investigator:
Last name:
Jason Denbo, MD
Email:
Sub-Investigator
Investigator:
Last name:
Jason Fleming, MD, FACS
Email:
Sub-Investigator
Investigator:
Last name:
Mokenge Malafa, MD
Email:
Sub-Investigator
Investigator:
Last name:
Jennifer Permuth, PhD, MS
Email:
Sub-Investigator
Investigator:
Last name:
Raj Mohan Paspulati, MD
Email:
Sub-Investigator
Start date:
October 6, 2022
Completion date:
February 2026
Lead sponsor:
Agency:
H. Lee Moffitt Cancer Center and Research Institute
Agency class:
Other
Source:
H. Lee Moffitt Cancer Center and Research Institute
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05692596
https://www.moffitt.org/clinical-trials-research/clinical-trials/
